• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    13.80 Up 0.30(2.22%) 4:00PM EST
    Add to Portfolio
    Prev Close:13.50
    Open:13.80
    Bid:13.57 x 500
    Ask:13.96 x 200
    1y Target Est:26.92
    Beta:1.41
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:13.55 - 14.02
    52wk Range:12.58 - 40.00
    Volume:1,208,822
    Avg Vol (3m):1,723,560
    Market Cap:570.06M
    P/E (ttm):N/A
    EPS (ttm):-2.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SRPT

    Comparison

    Symbol% ChgMkt Cap
    SRPTUp 2.22%570.06M
    ALNYUp 3.07%7.65B
    GSKUp 2.97%104.07B
    ISISUp 3.60%7.04B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):45.13
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-3.15
    Quarterly EPS Est (Dec-14) :-0.86
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):22.70

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback